Management Strategy of Polypoid Lesions of the Gallbladder

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

We retrospectively review a single-center cohort of gallbladder polyps from January 2015 to May 2020. Univariate and multivariable analyses were performed to extract potential risky factors of neoplastic polyps. Also, a comparison was conducted between laparoscopic cholecystectomy (LC) and laparoscopic polypectomy (LP) to explore factors affecting surgeons' decision on LC or LP.

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT04670952` - Potential Pulmonary Benefit of Low Pressure Laparoscopic Cholecystectomy in Selected Patients	N/A

NCT number	NCT04762797
Study type	Observational
Source	Peking Union Medical College Hospital
Contact
Status	Completed
Phase
Start date	January 1, 2015
Completion date	December 31, 2020

Management Strategy of Polypoid Lesions of the Gallbladder

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms